CD44 and hepatocellular carcinoma: We hypothesized that aberrant methylation in the HCC cells mediated by dysregulated NNMT may alter m6A abundance in the CD44 mRNA, thereby increasing the proportion of CD44V3 splice variant in these cells and accelerating tumor progression.